Newsroom Navigation

Contact Info:
Office of Public Affairs
2000 Circle of Hope,
Salt Lake City, UT 84112

public.affairs@hci.utah.edu

801-587-7639

In the Media

In The Media

Cases of Aggressive Prostate Cancer on the Rise, Research Finds

Cases of aggressive prostate cancer appear to be on the rise, researchers reported Tuesday. The good news is it's still rare for prostate cancer to spread. Just 3 percent of cases have already started spreading when men are diagnosed and prostate cancer overall has not become more common, the team found. And the American Cancer Society strongly questioned the findings and the methods used to get them.

Read More

In The Media

Physician-assisted suicide, euthanasia: increasingly legal but still rare

Legalized euthanasia and physician-assisted suicide are mainly used by patients with cancer, but remain rare, according to a new analysis of such programs. In the last year alone, California has legalized physician-assisted suicide, Canada legalized both physician-assisted suicide and euthanasia, and Colombia performed its first legal euthanasia, said John Urwin, a study author from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. "In order to inform current debates, it's imperative to understand current laws and practices."

Read More

Toward True Health: Fight cancer with good nutrition
In The Media

Toward True Health: Fight cancer with good nutrition

Question: With so many people affected by cancer, why is there so little information about the role of nutrition in cancer care? Sugar specifically? Answer: “It puzzles me why the simple concept ‘sugar feeds cancer’ can be so dramatically overlooked as part of a comprehensive cancer treatment plan” writes registered dietician Patrick Quillin, former director of nutrition for Cancer Treatment Centers of America in Tulsa, Okla. (Nutrition Science News, April 2000).

Read More

In The Media

Researchers identify new drug target for treating children with CNS-PNET

Primitive neuroectodermal tumors (PNETs) are the largest group of malignant brain tumors in children. They can arise from the brain's cerebellum or, more rarely, from tissue located throughout the central nervous system (CNS). Little is known about how CNS-PNETs develop, although these tumors are more aggressive than other PNETs and have an overall survival rate of only about 20 percent. In a new study, researchers for the first time have identified a possible target for a new CNS-PNET therapy.

Read More

In The Media

First Drug Target Identified for Children with Rare Type of Brain Tumor

Primitive neuroectodermal tumors (PNETs) are the largest group of malignant brain tumors in children. They can arise from the brain's cerebellum or, more rarely, from tissue located throughout the central nervous system (CNS). Little is known about how CNS-PNETs develop, although these tumors are more aggressive than other PNETs and have an overall survival rate of only about 20 percent. In a new study, researchers for the first time have identified a possible target for a new CNS-PNET therapy.

Read More

In The Media

Drug Combo Reduces Duodenal Polyp Development

Treatment with a two-drug therapy of sulindac and erlotinib reduces the development of precancerous duodenal polyps in patients with familial adenomatous polyposis (FAP), according to a new study presented at the 2016 annual meeting of the American Association for Cancer Research (AACR) and published in Journal of the American Medical Association

Read More

Ovarian Cancer Symptoms and Treatments
In The Media

Ovarian Cancer Symptoms and Treatments

Ovarian cancer accounts for about three percent of cancers among women, but it causes more deaths than any other cancer of the female reproductive system - like uterine, cervix, Fallopian tube, vulvar and vaginal cancer The reason for this is ovarian cancer is almost always detected at advanced stages (meaning the tumor has typically spread by the time it is diagnosed). Due to this, it is very difficult to cure ovarian cancer.

Read More

Join Mark Koelbel and Timp Harley for the 2016 Ride For Life
In The Media

Join Mark Koelbel and Timp Harley for the 2016 Ride For Life

Salt Lake City — (KUTV) The 2016 Ride for Life is scheduled for Saturday July 9th and proceeds will benefit the Huntsman Cancer Institute. Tickets can be purchased at the Timpanogas Harley Davidson store in Lindon. The ride will start there and then end at the USANA Ampitheater.

Read More

HCI Convenes Cancer Moonshot Summit
In The Media

HCI Convenes Cancer Moonshot Summit

Huntsman Cancer Institute (HCI) at the University of Utah participated in a national summit on the Cancer Moonshot initiative on June 29, 2016. The Cancer Moonshot Summits were organized at the request of Vice President Joe Biden, and more than 270 organizations hosted summits that brought together patients and survivors, researchers, physicians, advocates, philanthropists, and data and technology experts to brainstorm ways of speeding up progress in cancer prevention, diagnosis, treatment, and care over the next five years—and to ultimately end cancer as we know it.

Read More

New trial gives hope to terminal cancer patients
In The Media

New trial gives hope to terminal cancer patients

Breast cancer is far too common. In fact, one in eight women will be diagnosed with the disease in her lifetime. Many will be treated with chemotherapy and radiation, giving them a strong chance of survival, but about 30%, more than 75,000 each year, will face a metastasized cancer that isn't curable.

Read More

Massive crowds hit Hill Air Force Base
In The Media

Massive crowds hit Hill Air Force Base

It was a special day for University of Utah Doctor Jason Hunt. He's the clinical director of head and neck surgical oncology at the huntsman cancer institute. He got to ride in an F-16 as part of their ‘Hometown Hero’ program.

Read More

Pig on the Plaza
In The Media

Pig on the Plaza

Famous Dave's BBQ is helping raise money for the Huntsman Cancer Institute by selling $6 lunch plates at the Gallivan Plaza on Friday. It starts at 11 a.m. Stop by to grab a bite for a good cause!

Read More

In The Media

Detecting brain cancer without surgery

When a brain tumor is suspected because of symptoms such as headaches or other problems, its presence is usually confirmed by anatomical imaging such as CT or MRI. But through imaging, doctors often can't say much about the tumor - molecularly - besides 'something's in there.' Surgery and a biopsy are necessary to get a glimpse of the cancer cells themselves.

Read More

Dalai Lama visits Utah Tibetan Community Center and speaks to community
In The Media

Dalai Lama visits Utah Tibetan Community Center and speaks to community

His Holiness the 14th Dalai Lama of Tibet met with patients and leaders from the Huntsman Cancer Institute and University of Utah Tuesday before speaking to the Utah community at the University’s Jon M. Huntsman Center. Emma Houston, and HCI breast cancer survivor had the opportunity to meet with the Dalai Lama.

Read More

In The Media

Kailos Genetics and Huntsman Cancer Institute Awarded $2.4 Million Grant for ctDNA Test Development

Kailos Genetics, a personalized medicine information company offering leading-edge gene-based testing, today announced they have entered into a collaboration with Huntsman Cancer Institute (HCI) at the University of Utah to develop a clinical-grade test for circulating tumor DNA (ctDNA). Backed by a $2.4 million grant from the National Institutes of Health (NIH), the minimally invasive test will be used to monitor patients for breast cancer disease recurrence.

Read More


Our media relations representatives are here to help reporters Monday-Friday, 7:30 am-5 pm.

Debby Rogers
Public Affairs Manager
Phone: 801-587-7639
debby.rogers@hci.utah.edu

Amie Parker
Public Relations Associate
Phone: 801-213-5755
amie.parker@hci.utah.edu

Jill Woods
Administrative Assistant
Phone: 801-585-5321
Fax: 801-585-0900
jill.woods@hci.utah.edu

After-hours calls: Reporters calling before or after business hours on an urgent matter can page the University of Utah Health on-call media relations representative at 801-581-7387 and press 1.